Physician

Gregory J Litton, M.D.

According to 2025 Medicare claims, Gregory Litton, M.D. (NPI: 1487603916) practices medical oncology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84107-5701. Litton is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), Aledade 151 Northern Territories MSSP Enhanced (ACO ID: A5349), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Litton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 363 traditional Medicare patients, billed 61,191 HCPCS/CPT codes, and received $1,082,232 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,053 prescription claims across 206 beneficiaries totaling $4,870,929 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 12 claims. Open Payments data shows 53 records totaling $2,997. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,321,334 to $4,870,929. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,207 and ending at $640.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	350	66,778	$1,050,760
2016	332	76,500	$1,306,048
2017	417	74,209	$1,449,943
2018	412	100,800	$1,832,060
2019	465	81,028	$1,865,817
2020	431	78,975	$2,196,500
2021	439	97,038	$2,406,951
2022	344	76,075	$1,615,935
2023	338	56,713	$1,202,609
2024	363	61,191	$1,082,232

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	174	843	$1,321,334
2016	218	1,024	$2,594,313
2017	192	834	$2,272,580
2018	214	980	$2,385,576
2019	230	1,090	$2,730,498
2020	227	1,123	$3,701,474
2021	237	1,089	$4,586,074
2022	229	1,018	$4,398,232
2023	212	959	$4,753,238
2024	206	1,053	$4,870,929

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	32	$1,618
2016	N/R	39	$3,123
2017	N/R	54	$16,896
2018	N/R	59	$10,581
2019	N/R	77	$7,535
2020	N/R	49	$4,269
2021	N/R	36	$2,930
2022	N/R	58	$2,095
2023	N/R	58	$8,853
2024	N/R	12	$451

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	174	338	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	106	138	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	138	349	$12
80053	Blood test, comprehensive group of blood chemicals	143	358	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	164	456	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	51	1,428	$822,821
Revlimid	Lenalidomide	35	980	$548,306
Pomalyst	Pomalidomide	26	728	$463,581
Tibsovo	Ivosidenib	12	360	$399,849
Cabometyx	Cabozantinib S-Malate	12	360	$312,234

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$451

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$2,997	Cornerstone Specialty Network LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	4	$9,521	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Gregory J. Litton, M.D.?

Tedicare shows public-source Medicare data for Gregory J. Litton, M.D. (NPI 1487603916), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory J. Litton, M.D. have ACO affiliation data?

Gregory J. Litton, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), Aledade 151 Northern Territories MSSP Enhanced (MSSP, ACO ID A5349), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Gregory J. Litton, M.D.?

Gregory J. Litton, M.D. is linked to UTAH CANCER SPECIALISTS PC (billing NPI 1619925369) in the available physician profile data.

Does Gregory J. Litton, M.D. have Open Payments data?

Gregory J. Litton, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.